PanCAN President and CEO Julie Fleshman, JD, MBA, welcomes a panel of pancreatic cancer experts for an hour-long question-and-answer session discussing:
• The latest efforts to detect pancreatic cancer
• Pancreatic cancer risk factors, including genetic factors and clinical indications
• Novel blood tests
• PanCAN’s investment in early detection and the launch of the Early Detection Initiative
• And much more!
Julie M. Fleshman, JD, MBA,
PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes
Lynn Matrisian, PhD, MBA
PanCAN Chief Science Officer, bringing extensive cancer research experience and business training to provide strategic direction for the scientific aspects of PanCAN’s clinical and research initiatives
Rosalie Sears, PhD
Co-Director, Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute Oregon Health & Science University, Professor, Dept. of Molecular and Medical Genetics Krista L. Lake Chair in Cancer Research
Brian M. Wolpin, MD, MPH
Chief, Division of Gastrointestinal Oncology, Dana-Farber Cancer Institute, Robert T. & Judith B. Hale Chair in Pancreatic Cancer, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School
THANK YOU TO OUR WEBINAR SPONSORS
Thank you to our Scientific & Medical Affairs Industry Members
We're looking forward to sharing about the latest efforts to detect pancreatic cancer, including PanCAN's own Early Detection Initiative. Add this event to your calendar and save pancan.org/edievent for webinar day, Thursday, April 15, at 11 a.m. PT / 2 p.m. ET. Add to Calendar
(If you're prompted to download an iCalendar file, save it to your device and open it)
To begin watching, enter the email address you used to RSVP for the event.
DIDN'T RSVP? Sign up now and get immediate access to the event.